Table 1 Hepatitis C micro-elimination progress in target populations in the Netherlands in 2017
From: Strategies for achieving viral hepatitis C micro-elimination in the Netherlands
| Â | Population size (N) | HCV seroprevalence (%) | Total chronic HCV infections (HCV RNA (+)) (N) | HCV infections cured (N)/(%) | Source/Comments | Main actions/interventions to facilitate HCV elimination |
|---|---|---|---|---|---|---|
HIV-infected | 22,900 | 12% | 1471 (R) | 1124/76% | • Behavioral counseling. • Once in a lifetime or frequentc screening (depending on risk behavior). | |
Hemophilia patients (born < 1992) | NA | NA | 700 (R) | 190/27.1% | [25] (Combined Dutch & UK cohort) | • Once in a lifetime screening. • Treatment scale-up. |
High-risk MSM (HIV-negative)b | NA | 4,8% | NA | NA/NA | [57] | • Behavioral counseling. • Frequentc screening • Early treatment in case of (re) infection. |
Migrants from high endemic countries | 1,527,032 | NA | 13,819 (E) | NA/NA | [58] | • Raise awareness of HCV through local/multimedia information campaigns. • Once in a lifetime screening for first-generation migrants with HCV prevalence ≥2% in country of origin. |
PWID | 14,000 | 39–74% | 4040–7666 (C) | NA/NA | • Once in a lifetime or frequentc screening (depending on risk behavior). • Treatment scale up. | |
Prisoners | 10,194/each day | 7.4–13.9% | 558–1049 (C) | NA/NA | • Educate prison doctors on HCV. • Once in a lifetime or frequentc screening (depending on risk behavior). • Include detainees in regular health insurance. | |
Hemodialysis patients | 17,132 | NA | NA | NA/NA | [63] | • Once in a lifetime screening. |
Health care workersd | NA | NA | NA | NA/NA | – | • Once in a lifetime screening by employer. |
General Dutch population | 17,081,507a | 0.1–0.4% | 12,640–50,561 (C) | 4427/8–35% | • Raise awareness of HCV through multimedia information campaigns. • Educate general practitioners on HCV to increase compliance with viral hepatitis screening and referral guidelines. • Trace and treat HCV infected lost to follow-up. |